The cancer treatment developer is set to go public in an offering which would represent exits for Pfizer Ventures, Leaps by Bayer and Ipsen.
Arctos Medical, which is developing gene therapies to treat sight loss, had raised $8.1m from investors including Novartis two years ago.
University of Bern spinout Arctos Medical has been acquired by existing shareholder Novartis.
Oracle has signed up to be a cornerstone investor for Oxford Nanopore’s initial public offering, putting up half of the $410m target.
Ideo contributed to female-focused debit card provider Sequin's $5m seed round while Nikon has exited motion data software developer Wrnch.
Foxconn and GoTo Group are contributing to a $250m PIPE deal for the Engie, Panasonic and Sumitomo-backed electric scooter system provider’s reverse takeover.
GV owns a 6.6% stake in the DevOps platform developer, which was valued at $6bn as of a secondary share sale late last year.
The Intel Capital-backed employee management software provider was taken over by HighBar for an undisclosed amount.
JSR is buying semiconductor manufacturing technology producer Inpria, giving an exit to fellow corporates SK Hynix, TSMC, Intel, Air Liquide, Applied Materials and Samsung.
Hinge Health has bought Wrnch, a computer vision technology developer exploiting research from Concordia University.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
